Andrew Lewandowski

953 total citations
21 papers, 241 citations indexed

About

Andrew Lewandowski is a scholar working on Pediatrics, Perinatology and Child Health, Genetics and Pharmacology. According to data from OpenAlex, Andrew Lewandowski has authored 21 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 5 papers in Genetics and 4 papers in Pharmacology. Recurrent topics in Andrew Lewandowski's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Infant Development and Preterm Care (2 papers). Andrew Lewandowski is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Infant Development and Preterm Care (2 papers). Andrew Lewandowski collaborates with scholars based in United States, Switzerland and Singapore. Andrew Lewandowski's co-authors include Ian M. Paul, Laura P. James, Susan M. Abdel‐Rahman, Chiara Melloni, Ram Yogev, Andrew M. Atz, Brenda B. Poindexter, Michael Cohen‐Wolkowiez, Susan R. Mendley and Daniel González and has published in prestigious journals such as Blood, PEDIATRICS and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Andrew Lewandowski

21 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Lewandowski United States 9 49 41 37 36 36 21 241
A. Binning United Kingdom 9 23 0.5× 21 0.5× 35 0.9× 21 0.6× 70 1.9× 17 375
Joshua L. Rein United States 9 47 1.0× 6 0.1× 8 0.2× 62 1.7× 24 0.7× 21 384
Hiroki Nishiwaki Japan 11 7 0.1× 11 0.3× 25 0.7× 20 0.6× 26 0.7× 64 301
Anwar Habib India 10 9 0.2× 15 0.4× 17 0.5× 7 0.2× 57 1.6× 30 359
Ricardo M.R. Meirelles Brazil 12 27 0.6× 7 0.2× 9 0.2× 17 0.5× 50 1.4× 22 297
Robert Sawicki Poland 12 22 0.4× 6 0.1× 22 0.6× 59 1.6× 38 1.1× 34 384
İbrahi̇m Karayaylalı Türkiye 10 43 0.9× 5 0.1× 12 0.3× 17 0.5× 19 0.5× 38 281
Delong Zhao China 9 31 0.6× 8 0.2× 16 0.4× 4 0.1× 13 0.4× 27 255
Andrej Belančić Croatia 10 12 0.2× 43 1.0× 3 0.1× 15 0.4× 43 1.2× 71 346
Ken‐Soon Tan Australia 9 8 0.2× 20 0.5× 38 1.0× 7 0.2× 21 0.6× 19 203

Countries citing papers authored by Andrew Lewandowski

Since Specialization
Citations

This map shows the geographic impact of Andrew Lewandowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Lewandowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Lewandowski more than expected).

Fields of papers citing papers by Andrew Lewandowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Lewandowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Lewandowski. The network helps show where Andrew Lewandowski may publish in the future.

Co-authorship network of co-authors of Andrew Lewandowski

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Lewandowski. A scholar is included among the top collaborators of Andrew Lewandowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Lewandowski. Andrew Lewandowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woo, Janghee, Darlene Lu, Andrew Lewandowski, et al.. (2023). Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial. Blood Advances. 7(24). 7471–7484. 23 indexed citations
2.
Barba, Pere, Junichiro Yuda, Maria Lia Palomba, et al.. (2023). A Phase 1 Study of PIT565, a First-in-Class, Anti-CD3, Anti-CD19, Anti-CD2 Trispecific Antibody in Patients with Relapsed and/or Refractory B-Cell Malignancies. Blood. 142(Supplement 1). 3099–3099. 3 indexed citations
3.
4.
Chávez, Julio C., Frederick L. Locke, Carl G. Simon, et al.. (2020). Ibrutinib before Apheresis May Improve Tisagenlecleucel Manufacturing in Relapsed/Refractory Adult Diffuse Large B-Cell Lymphoma: Initial Results from a Phase 1b Study. Blood. 136(Supplement 1). 3–4. 7 indexed citations
5.
Smith, P. Brian, C. Michael Cotten, Mark L. Hudak, et al.. (2019). Rifampin Pharmacokinetics and Safety in Preterm and Term Infants. Antimicrobial Agents and Chemotherapy. 63(6). 8 indexed citations
6.
7.
Atz, Andrew M., Ram Yogev, Janice E. Sullivan, et al.. (2018). A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data. Journal of Pharmacokinetics and Pharmacodynamics. 45(3). 419–430. 11 indexed citations
8.
Hornik, Christoph P., Daniel González, John van den Anker, et al.. (2018). Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children. The Journal of Clinical Pharmacology. 58(8). 1092–1104. 12 indexed citations
9.
Ku, Lawrence, Rachel G. Greenberg, Christoph P. Hornik, et al.. (2018). Furosemide and Bumetanide Use and Clinical Outcomes in Extremely Low Birth Weight Infants. PEDIATRICS. 142(1_MeetingAbstract). 183–183. 1 indexed citations
10.
Mclaughlin, Matthew, Yang He, Janice Brunstrom-Hernandez, et al.. (2017). Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral Palsy. PM&R. 10(3). 235–243. 24 indexed citations
11.
Abdel‐Rahman, Susan M., Ian M. Paul, Laura P. James, et al.. (2017). A Weight Estimation Strategy for Preterm and Full-Term Infants. Global Pediatric Health. 4. 2333794X17748775–2333794X17748775. 1 indexed citations
12.
Autmizguine, Julie, Chiara Melloni, Christoph P. Hornik, et al.. (2017). Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children. Antimicrobial Agents and Chemotherapy. 62(1). 21 indexed citations
13.
Abdel‐Rahman, Susan M., Ian M. Paul, Laura P. James, et al.. (2017). An anthropometric survey of US pre-term and full-term neonates. Annals of Human Biology. 44(8). 678–686. 6 indexed citations
14.
Estepp, Jeremie H., Chiara Melloni, Courtney D. Thornburg, et al.. (2015). Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia. The Journal of Clinical Pharmacology. 56(3). 298–306. 15 indexed citations
15.
Hammer, Gregory B., Andrew Lewandowski, David R. Drover, et al.. (2015). Safety and Efficacy of Sodium Nitroprusside During Prolonged Infusion in Pediatric Patients. Pediatric Critical Care Medicine. 16(5). 397–403. 15 indexed citations
16.
González, Daniel, Chiara Melloni, Brenda B. Poindexter, et al.. (2015). Simultaneous Determination of Trimethoprim and Sulfamethoxazole in Dried Plasma and Urine Spots. Bioanalysis. 7(9). 1137–1149. 27 indexed citations
17.
Abdel‐Rahman, Susan M., Ian M. Paul, Laura P. James, & Andrew Lewandowski. (2013). Evaluation of the Mercy TAPE: Performance Against the Standard for Pediatric Weight Estimation. Annals of Emergency Medicine. 62(4). 332–339.e6. 44 indexed citations
18.
Hammer, Gregory B., Scott R. Schulman, Andrew Lewandowski, et al.. (2013). Sodium nitroprusside is not associated with metabolic acidosis during intraoperative infusion in children. BMC Anesthesiology. 13(1). 9–9. 4 indexed citations
19.
Lewandowski, Andrew. (2010). Population Monte Carlo methods with applications in Bayesian statistics. Purdue e-Pubs (Purdue University System). 1 indexed citations
20.
Lewandowski, Andrew, et al.. (1993). [Occurrence of epistaxis in relation to seasonal factors].. PubMed. 46(15-16). 597–602. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Binning Breakdown of academic impact, for papers by Joshua L. Rein Breakdown of academic impact, for papers by Hiroki Nishiwaki Breakdown of academic impact, for papers by Anwar Habib Breakdown of academic impact, for papers by Ricardo M.R. Meirelles Breakdown of academic impact, for papers by Robert Sawicki Breakdown of academic impact, for papers by İbrahi̇m Karayaylalı Breakdown of academic impact, for papers by Delong Zhao Breakdown of academic impact, for papers by Andrej Belančić Breakdown of academic impact, for papers by Ken‐Soon Tan
Rankless by CCL
2026